# Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions

> **NCT07675226** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Oscotec Inc.** · enrollment: 48 (estimated)

## Conditions studied

- Bioequivalence Study in Healthy Subjects
- Immune Thrombocytopenia (ITP)
- Rheumatoid Arthritis (RA)

## Interventions

- **DRUG:** SKI-O-703 API in Capsules
- **DRUG:** SKI-O-703 Formulated Granules in Capsules

## Key facts

- **NCT ID:** NCT07675226
- **Lead sponsor:** Oscotec Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-07-10
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675226, "Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*